Sage Therapeutics, Inc.
SAGEDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597553
Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.
Q4 2025 vs. Q3 2025
How the institutions holding Sage Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 5 | 2 | −3 |
| Shares | 56.4K | 22.2K | −34.2K (−60.6%) |
| Value | $494.0K | $460.0K | −$34.0K (−6.9%) |
New holders (0)
Institutions that held Sage Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
None.
Sold out (3)
Institutions that held Sage Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Advisor Group Holdings, Inc. | 4,045 | $35.1K |
| IFP Advisors, Inc | 445 | $3.86K |
| XTX Topco Ltd | 29,698 | $0 |